PROJECTS

The Strategic Clarity Consulting team has worked on a variety research commercialization projects with clients in both the academic and industry sectors. Our strategic advising services are offered to assist clients at all phases of the innovation continuum including very early stage invention assessment through technology development. When first engaging with a potential client, Strategic Clarity Consulting takes the time to carefully listen to the advisement needs of the client. In this way, Strategic Clarity Consulting ensures that its services are appropriately tailored to the project and importantly; are consistent with the expectations of the client. We believe this approach fosters productive relationships and promotes positive outcomes for our clients.

The following is a limited sampling of projects in which Strategic Clarity Consulting has provided expert advisement assistance to technology research organizations.

  • Numerous evaluations of invention disclosures from research innovators
  • Reviewer of innovation grant proposals on behalf of a major research university
  • Advised major academic organizations in the northeast and Texas regarding the formation of numerous venture capital and private investor backed startups
  • Provided startup advisement services to independent scientists-entrepreneurs with early stage medical device technologies
  • Structured and negotiated scores of licensing agreements for therapeutic and diagnostic technologies on behalf of academic and biopharma research organizations
  • Provided mentorship of technology transfer staff
  • Advised leadership at major medical centers regarding internal IP policies
  • Structured and negotiated numerous joint IP agreements between academic research centers
  • Developed awareness documents for technology transfer offices for major academic research organizations
  • Structured and negotiated numerous academic and industry research collaborations, including several with multi-year research funding support
  • Negotiated several investigator-initiated clinical trial agreements on behalf of a northeast medical center